(Q28371764)

1

0 references

T Otake

2

0 references

I Oishi

3

0 references

T Kurimura

Antiviral Chemistry & Chemotherapy

4

0 references

language of work or name

English

0 references

publication date

January 1999

0 references

published in

0 references

volume

10

0 references

issue

1

0 references

page(s)

15-21

0 references

cites work

Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Three-dimensional structure of a mutant HIV-1 protease displaying cross-resistance to all protease inhibitors in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Clinical correlation and genetic polymorphism of the human immunodeficiency virus proviral DNA obtained after polymerase chain reaction amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Pharmacokinetic Analysis of Dextran Sulfate in Rats as Pertains to Its Clinical Usefulness for Therapy of HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Dextran sulfate is poorly absorbed after oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Potent inhibitory effect of a series of modified cyclodextrin sulfates (mCDS) on the replication of HIV-1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

A new candidate for an anti-HIV-1 agent: modified cyclodextrin sulfate (mCDS71).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Genetic subtypes of HIV-1 in the Philippines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102

Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000102